http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c191f7dd71ed9c71a349df77b4e691a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Frigault |
| name | Matthew J Frigault Matthew J. Frigault |
| given-name | Matthew J Matthew J. |
| organization-name | Cancer Center Massachusetts General Hospital Boston Massachusetts USA; Department of Medicine Harvard Medical School Boston Massachusetts USA Cellular Immunotherapy Program, Cancer Center Massachusetts General Hospital Boston Massachusetts USA; Department of Pathology and Department of Medicine Harvard Medical School Boston Massachusetts USA Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA 1Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Cellular Therapy Service, Massachusetts General Hospital, Boston, MA; From the Departments of Medicine (H.H., M.J.F.), Radiology (H.R.K.), and Pathology (L.R.M.), Massachusetts General Hospital, the Departments of Medicine (H.H., M.J.F.), Radiology (H.R.K.), and Pathology (L.R.M.), Harvard Medical School, and the Department of Radiology, Massachusetts Eye and Ear (H.R.K.) — all in Boston; and the Department of Medicine, Montefiore Medical Center, New York (E.A.M.). Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA; 6Cellular Immunotherapy Program, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Charlestown, MA;; Harvard Medical School, Boston, MA; Department of Biology, College of the Holy Cross, 1 College Street, Worcester, MA 01610; Cellular Immunotherapy Program Massachusetts General Hospital Cancer Center Boston Massachusetts USA Bone Marrow Transplantation Program, Massachusetts General Hospital, Boston, MA; Massachusetts General Hospital 1Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School; Cellular Immunotherapy Program Massachusetts General Hospital Boston Massachusetts USA Department of Medicine,; Cellular Immunotherapy Program, and ABRAMSON CANCER CENTER Cellular Immunotherapy Program, Division of Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School , Boston, MA 02114 , USA; Division of Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School , Boston, MA 02114 , USA Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA;; Department of Medicine, Harvard Medical School, Boston, MA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital , Boston, Massachusetts , USA; Division of Hematology and Oncology, Massachusetts General Hospital , Boston, Massachusetts , USA; Department of Medicine, Harvard Medical School , Boston, Massachusetts , USA Cellular Immunotherapy Program and Abramson Cancer Center and the Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Massachusetts General Hospital Cancer Center, Harvard Medical School , Building 149, 13th Street, Room 7.219, Charlestown, Boston, MA 02129 , USA The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group Division of Hematology and Oncology Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA 1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts.; 3Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, Massachusetts. 1Center for Cancer Research and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA; 2Department of Medicine, Harvard Medical School, Boston, MA; 3Department of Pathology, Harvard Medical School, Boston, MA Division of Hematology‐Oncology, Department of Medicine Massachusetts General Hospital Boston Massachusetts Harvard Medical School, Department of Medicine, Boston, Massachusetts, USA; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA Massachusetts General Hospital Cancer Center, Boston, MA Department of Medicine, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, Massachusetts , USA Harvard Medical School, Boston, MA;; Cancer Center, Massachusetts General Hospital, Boston, MA; Division of Hematology & Oncology Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA Harvard Medical School Boston Massachusetts 02115 USA; Cellular Immunotherapy Program Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 USA; Blood and Marrow Transplant Program Massachusetts General Hospital Boston Massachusetts 02114 USA |
Incoming Links
Total number of triples: 108.